Itragerm (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform needed to convert lanosterol into ergosterol. Without ergosterol, the fungal cell membrane cannot form properly, leading to increased permeability and inhibition of fungal growth. This mechanism provides fungistatic activity against many yeasts and molds.

The exact dose of Itragerm is set by the prescribing clinician based on the type and severity of the fungal infection, the patient’s weight, liver function, and any concomitant medications. Itraconazole dosing regimens vary widely, so patients should follow the specific instructions provided by their healthcare professional.

Safety data for itraconazole in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To request Itragerm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with fluconazole, itraconazole offers a broader spectrum against molds such as Aspergillus and dimorphic fungi, but it has a higher potential for drug‑drug interactions due to strong CYP3A4 inhibition. It is generally more potent for systemic mycoses, while fluconazole is often preferred for uncomplicated Candida infections because of its simpler interaction profile.

Itragerm should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct sunlight, and avoid storing it in places where temperature fluctuations are common, such as near radiators or in a vehicle.

Itragerm is taken orally, usually as a tablet or capsule, and should be swallowed whole with a full glass of water. It can be taken with or without food, but consistent intake with respect to meals helps maintain stable absorption. Patients should not crush or chew the dosage form unless specifically instructed by a healthcare professional.

The most serious adverse effects of itraconazole include hepatotoxicity, which can present as jaundice or elevated liver enzymes, and congestive heart failure due to fluid retention. Severe cutaneous reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis are rare but life‑threatening and require immediate medical attention.

Itragerm should be avoided in patients with known hypersensitivity to itraconazole or any azole antifungal, those with severe hepatic impairment, and individuals with existing congestive heart failure. Caution is also advised for patients taking medications that strongly interact with CYP3A4, as well as for pregnant or nursing women unless the benefits clearly outweigh the risks.